Skip to main content

Articles

The Oncology Drug Pipeline Robust with Novel Agents

Payers Collaborate with Providers to Adopt Oncology Pathways, New Care Delivery Models

Family History of Cancer/Genetic Counseling Often Lacking for Patients First Presenting with Malignancy

For Advanced GIST, Regorafenib Shows Robust Effect

Cancer Screening Is Cost-Effective, Saves Lives

Cancer Therapies in Short Supply Prompt a Response at the Federal Level

High OOP Costs for Medicare Patients with Cancer

The Cost of Lung Cancer at the End of Life: Early Institution of Palliative Care Improves Survival

Why Hasn’t Genomic Testing Changed the Landscape?

Radiotherapy-Related Hospital Admissions Are Frequent

Page 199 of 244
Results 1981 - 1990 of 2436